[
  {
    "title": "微芯生物副总经理宁志强、赵疏梅辞职 2022年前三季度公司亏损4221.12万",
    "href": "http://stock.jrj.com.cn/2023/01/05195237262323.shtml",
    "datetime": "2023-01-05 19:52:35",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：核心技术人员宁志强和高管赵疏梅退休离职",
    "href": "http://stock.jrj.com.cn/2023/01/05173937261738.shtml",
    "datetime": "2023-01-05 17:39:29",
    "code": "688321"
  },
  {
    "title": "微芯生物股东博奥生物减持821.44万股 套现1.97亿 2022年前三季度公司亏损4221.12万",
    "href": "http://stock.jrj.com.cn/2022/12/02195237185590.shtml",
    "datetime": "2022-12-02 19:52:54",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：博奥生物完成减持2%股份",
    "href": "http://stock.jrj.com.cn/2022/12/02165537184784.shtml",
    "datetime": "2022-12-02 16:55:00",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：拟使用不超3000万美元闲置自有美元资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/11/09172637124516.shtml",
    "datetime": "2022-11-09 17:26:36",
    "code": "688321"
  },
  {
    "title": "微芯生物披露2022年半年报 实现营收2.16亿元",
    "href": "http://stock.jrj.com.cn/2022/08/23093036924137.shtml",
    "datetime": "2022-08-23 09:30:52",
    "code": "688321"
  },
  {
    "title": "微芯生物2022年上半年亏损1928.83万同比亏损增加 研发费用增加",
    "href": "http://stock.jrj.com.cn/2022/08/23091136923947.shtml",
    "datetime": "2022-08-23 09:11:56",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：上半年净亏损1928.83万元",
    "href": "http://stock.jrj.com.cn/2022/08/22192236922672.shtml",
    "datetime": "2022-08-22 19:22:42",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：拟使用不超3亿元闲置募集资金和不超2亿元有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/08/05180536874484.shtml",
    "datetime": "2022-08-05 18:05:35",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：拟使用募集资金2.6亿元向成都微芯增资 以实施募投项目",
    "href": "http://stock.jrj.com.cn/2022/08/05180336874491.shtml",
    "datetime": "2022-08-05 18:03:20",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：约1.5763亿股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/08/03173936867226.shtml",
    "datetime": "2022-08-03 17:39:57",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：5亿元可转债将于7月28日起在上交所挂牌交易",
    "href": "http://stock.jrj.com.cn/2022/07/25194036841096.shtml",
    "datetime": "2022-07-25 19:40:34",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：拟引进外部投资者对微芯新域进行增资",
    "href": "http://stock.jrj.com.cn/2022/07/11205536800506.shtml",
    "datetime": "2022-07-11 20:55:40",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)披露可转债中签结果：中签号码共有21.929万个",
    "href": "http://stock.jrj.com.cn/2022/07/06170236787423.shtml",
    "datetime": "2022-07-06 17:02:23",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：向不特定对象发行可转债申请获证监会同意注册批复",
    "href": "http://stock.jrj.com.cn/2022/06/20181036743706.shtml",
    "datetime": "2022-06-20 18:10:44",
    "code": "688321"
  },
  {
    "title": "微芯生物全资子公司拟对微芯新域增资600万 增资完成后持股70%",
    "href": "http://stock.jrj.com.cn/2022/06/10211336720708.shtml",
    "datetime": "2022-06-10 21:13:13",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：成都微芯拟对微芯新域增资600万元",
    "href": "http://stock.jrj.com.cn/2022/06/10164536719539.shtml",
    "datetime": "2022-06-10 16:45:55",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼治疗广泛期小细胞肺癌Ib/II期临床试验申请获得批准",
    "href": "http://stock.jrj.com.cn/2022/05/31170236693531.shtml",
    "datetime": "2022-05-31 17:02:49",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)一季度净亏损373.18万元",
    "href": "http://stock.jrj.com.cn/2022/04/29174736505668.shtml",
    "datetime": "2022-04-29 17:47:52",
    "code": "688321"
  },
  {
    "title": "微芯生物2021年净利2195.83万减少29.3% 董事长XIANPING LU薪酬467.19万",
    "href": "http://stock.jrj.com.cn/2022/03/29205236157208.shtml",
    "datetime": "2022-03-29 20:52:44",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：2021年净利降29.27%至2195.83万元",
    "href": "http://stock.jrj.com.cn/2022/03/29172436149488.shtml",
    "datetime": "2022-03-29 17:24:08",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼胶囊临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/03/21182634856776.shtml",
    "datetime": "2022-03-21 18:26:56",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼治疗软组织肉瘤II期临床试验申请获得批准",
    "href": "http://stock.jrj.com.cn/2022/03/17160734839279.shtml",
    "datetime": "2022-03-17 16:07:43",
    "code": "688321"
  },
  {
    "title": "康方生物-B(09926.HK)与微芯生物合作，启动PD-1/CTLA-4双抗联合西奥罗尼临床研究治疗PD-(L)1经治ES-SCLC",
    "href": "http://stock.jrj.com.cn/2022/03/02061234510363.shtml",
    "datetime": "2022-03-02 06:12:38",
    "code": "688321"
  },
  {
    "title": "微芯生物2021年净利2198.4万同比减少29.19% 项目进展加速导致研发费用投入加大",
    "href": "http://stock.jrj.com.cn/2022/02/25183034465421.shtml",
    "datetime": "2022-02-25 18:30:30",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：拟参投设立医药产业投资基金",
    "href": "http://stock.jrj.com.cn/2022/02/18162834392235.shtml",
    "datetime": "2022-02-18 16:28:57",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：向不特定对象发行可转换公司债券申请获上交所科创板上市委员会审核通过",
    "href": "http://stock.jrj.com.cn/2022/02/17204234383126.shtml",
    "datetime": "2022-02-17 20:42:56",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：2名一致行动人股东完成减持3.64%股份",
    "href": "http://stock.jrj.com.cn/2022/01/23212334194956.shtml",
    "datetime": "2022-01-23 21:23:18",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西达本胺联合替雷利珠单抗治疗非小细胞肺癌II期临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2022/01/13154734153918.shtml",
    "datetime": "2022-01-13 15:47:05",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：清华大学持有的清华控股100%股权将无偿划转给四川能投",
    "href": "http://stock.jrj.com.cn/2021/12/12163633999500.shtml",
    "datetime": "2021-12-12 16:36:22",
    "code": "688321"
  },
  {
    "title": "微芯生物：清华控股100%股权拟无偿划转给四川能投",
    "href": "http://stock.jrj.com.cn/2021/12/12162633999482.shtml",
    "datetime": "2021-12-12 16:26:39",
    "code": "688321"
  },
  {
    "title": "微芯生物：西达本胺续约进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03162333960286.shtml",
    "datetime": "2021-12-03 16:23:07",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西达本胺续谈纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03161433960258.shtml",
    "datetime": "2021-12-03 16:14:00",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：股东LAV One及其一致行动人持股比例由6.98%减至5.98%",
    "href": "http://stock.jrj.com.cn/2021/12/01163433950036.shtml",
    "datetime": "2021-12-01 16:34:05",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西达本胺新适应症在日本获批上市",
    "href": "http://stock.jrj.com.cn/2021/12/01163133950020.shtml",
    "datetime": "2021-12-01 16:31:25",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：就申请向不特定对象发行可转债 收到审核问询函",
    "href": "http://stock.jrj.com.cn/2021/11/18190433873755.shtml",
    "datetime": "2021-11-18 19:04:16",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西达本胺联合替雷利珠单抗治疗非小细胞肺癌II期临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/11/09180533828387.shtml",
    "datetime": "2021-11-09 18:05:10",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：发行可转债申请获上交所受理",
    "href": "http://stock.jrj.com.cn/2021/11/01175033798876.shtml",
    "datetime": "2021-11-01 17:50:20",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)第三季度净亏损1710.26万元",
    "href": "http://stock.jrj.com.cn/2021/10/29164533777725.shtml",
    "datetime": "2021-10-29 16:45:51",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：LAV One及其一致行动人减持股份达5%",
    "href": "http://stock.jrj.com.cn/2021/10/20165633722231.shtml",
    "datetime": "2021-10-20 16:56:18",
    "code": "688321"
  },
  {
    "title": "微芯生物：国家药监局批准西格列他钠片上市",
    "href": "http://stock.jrj.com.cn/2021/10/19180033717450.shtml",
    "datetime": "2021-10-19 18:00:25",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：子公司1类创新药西格列他钠片获批上市",
    "href": "http://stock.jrj.com.cn/2021/10/19162433716667.shtml",
    "datetime": "2021-10-19 16:24:44",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：LAV One及其一致行动人减持股份达1.01%",
    "href": "http://stock.jrj.com.cn/2021/09/15191333440854.shtml",
    "datetime": "2021-09-15 19:13:17",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼治疗小细胞肺癌获得FDA孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2021/09/09164933409974.shtml",
    "datetime": "2021-09-09 16:49:20",
    "code": "688321"
  },
  {
    "title": "微芯生物2021年半年度亏损715.23万元 同比由盈转亏",
    "href": "http://stock.jrj.com.cn/2021/08/30115633350992.shtml",
    "datetime": "2021-08-30 11:56:34",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)半年度业绩盈转亏至715.23万元",
    "href": "http://stock.jrj.com.cn/2021/08/29193433341255.shtml",
    "datetime": "2021-08-29 19:34:37",
    "code": "688321"
  },
  {
    "title": "微芯生物全资子公司对外投资100万元在成都天府国际生物城投资设立全资子公司",
    "href": "http://stock.jrj.com.cn/2021/08/17230833269540.shtml",
    "datetime": "2021-08-17 23:08:24",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：成都微芯拟出资100万元投设全资子公司微芯新域",
    "href": "http://stock.jrj.com.cn/2021/08/17185933268282.shtml",
    "datetime": "2021-08-17 18:59:20",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：CS12192临床试验申请获FDA受理",
    "href": "http://stock.jrj.com.cn/2021/08/06170033213209.shtml",
    "datetime": "2021-08-06 17:00:24",
    "code": "688321"
  },
  {
    "title": "微芯生物：收到国家知识产权局出具的《无效宣告请求受理通知书》",
    "href": "http://stock.jrj.com.cn/2021/08/03180733196926.shtml",
    "datetime": "2021-08-03 18:07:39",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：200万股限售股将于8月12日上市流通",
    "href": "http://stock.jrj.com.cn/2021/08/03173633196565.shtml",
    "datetime": "2021-08-03 17:36:37",
    "code": "688321"
  },
  {
    "title": "微芯生物：累计回购375万股 用于员工股权激励",
    "href": "http://stock.jrj.com.cn/2021/08/02174133189888.shtml",
    "datetime": "2021-08-02 17:41:32",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：完成回购 累计耗资1.55亿元回购375万股",
    "href": "http://stock.jrj.com.cn/2021/08/02170933189647.shtml",
    "datetime": "2021-08-02 17:09:26",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼治疗三阴性乳腺癌获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2021/07/07131133057858.shtml",
    "datetime": "2021-07-07 13:11:31",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)7月6日首次回购17.55万股",
    "href": "http://stock.jrj.com.cn/2021/07/06165733053423.shtml",
    "datetime": "2021-07-06 16:57:38",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼治疗三阴性乳腺癌获批临床",
    "href": "http://stock.jrj.com.cn/2021/07/06165533053416.shtml",
    "datetime": "2021-07-06 16:55:23",
    "code": "688321"
  },
  {
    "title": "A股异动 | 微芯生物(688321.SH)跌6% 两股东合计拟减持不超6%公司股份",
    "href": "http://stock.jrj.com.cn/2021/07/06093433051109.shtml",
    "datetime": "2021-07-06 09:34:43",
    "code": "688321"
  },
  {
    "title": "微芯生物：LAVOne、Vertex因自身资金需要拟实施减持",
    "href": "http://stock.jrj.com.cn/2021/07/05173833048016.shtml",
    "datetime": "2021-07-05 17:38:29",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：LAV One、Vertex拟合计减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2021/07/05164033047657.shtml",
    "datetime": "2021-07-05 16:40:40",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：72.05万股限制性股票7月8日解锁上市",
    "href": "http://stock.jrj.com.cn/2021/07/05163833047643.shtml",
    "datetime": "2021-07-05 16:38:09",
    "code": "688321"
  },
  {
    "title": "微芯生物：两股东合计拟减持不超6%公司股份",
    "href": "http://stock.jrj.com.cn/2021/07/05163433047618.shtml",
    "datetime": "2021-07-05 16:34:46",
    "code": "688321"
  },
  {
    "title": "微芯生物2名股东合计减持1049.93万股 套现合计3.74亿",
    "href": "http://stock.jrj.com.cn/2021/07/02210433035342.shtml",
    "datetime": "2021-07-02 21:04:31",
    "code": "688321"
  },
  {
    "title": "微芯生物：产品西达本胺在日本获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/25105332994910.shtml",
    "datetime": "2021-06-25 10:53:11",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司产品西达本胺在日本获批上市 公司将获得对应里程碑收入及相应比例销售分成",
    "href": "http://stock.jrj.com.cn/2021/06/24170932990507.shtml",
    "datetime": "2021-06-24 17:09:24",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西达本胺在日本获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/24161032989862.shtml",
    "datetime": "2021-06-24 16:10:22",
    "code": "688321"
  },
  {
    "title": "微芯生物：近日获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2021/06/18102532952999.shtml",
    "datetime": "2021-06-18 10:25:16",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西达本胺胺联合恩沃利单抗治疗经PD-1抑制剂治疗耐药获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/17183832948807.shtml",
    "datetime": "2021-06-17 18:38:28",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司今年制定的375万股回购计划正在执行中",
    "href": "http://stock.jrj.com.cn/2021/06/11210832913963.shtml",
    "datetime": "2021-06-11 21:08:21",
    "code": "688321"
  },
  {
    "title": "微芯生物：CS23546/CS23547计划在2022年申请IND",
    "href": "http://stock.jrj.com.cn/2021/06/02191732864917.shtml",
    "datetime": "2021-06-02 19:17:19",
    "code": "688321"
  },
  {
    "title": "微芯生物：西格列他钠的最长专利保护期目前已延长至2034年",
    "href": "http://stock.jrj.com.cn/2021/06/02191432864906.shtml",
    "datetime": "2021-06-02 19:14:24",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司会在适当的阶段积极寻找合作伙伴来共同推进西奥罗尼在海外的后期临床开发和未来的商业化",
    "href": "http://stock.jrj.com.cn/2021/06/02191332864899.shtml",
    "datetime": "2021-06-02 19:13:21",
    "code": "688321"
  },
  {
    "title": "微芯生物：百济神州的BTK抑制剂目前还没有获批针对弥漫大B细胞淋巴瘤",
    "href": "http://stock.jrj.com.cn/2021/06/02190732864875.shtml",
    "datetime": "2021-06-02 19:07:05",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司参加了2021年5月22日―28日在北京举办的全国科技活动周",
    "href": "http://stock.jrj.com.cn/2021/06/02184132864656.shtml",
    "datetime": "2021-06-02 18:41:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：截止目前 西达本胺的最长专利保护期已延长至2038年 西格列他纳的最长专利保护期已延长至2034年",
    "href": "http://stock.jrj.com.cn/2021/06/02183532864595.shtml",
    "datetime": "2021-06-02 18:35:56",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼在前期的临床试验中 针对多线治疗失败的患者 其单药治疗取得了十分积极的疗效结果",
    "href": "http://stock.jrj.com.cn/2021/06/02182232864494.shtml",
    "datetime": "2021-06-02 18:22:47",
    "code": "688321"
  },
  {
    "title": "微芯生物：西格列他钠目前正在正常的行政审评审批中 现场验收已经顺利通过",
    "href": "http://stock.jrj.com.cn/2021/06/02181432864444.shtml",
    "datetime": "2021-06-02 18:14:07",
    "code": "688321"
  },
  {
    "title": "微芯生物：西达本胺续约进入国家医保目录 不包含新批准的乳腺癌适应症",
    "href": "http://stock.jrj.com.cn/2021/06/02181332864435.shtml",
    "datetime": "2021-06-02 18:13:14",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司今年制定的375万股回购计划正在执行中",
    "href": "http://stock.jrj.com.cn/2021/06/02181232864419.shtml",
    "datetime": "2021-06-02 18:12:20",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼（小细胞肺癌、卵巢癌）美国临床试验阶段性投资约为2237万美元",
    "href": "http://stock.jrj.com.cn/2021/06/02181232864420.shtml",
    "datetime": "2021-06-02 18:12:18",
    "code": "688321"
  },
  {
    "title": "A股异动 | 微芯生物(688321.SH)大涨逾8% 西格列他钠片获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2021/06/02144732862883.shtml",
    "datetime": "2021-06-02 14:47:48",
    "code": "688321"
  },
  {
    "title": "微芯生物：成都微芯获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2021/05/31173932850967.shtml",
    "datetime": "2021-05-31 17:39:44",
    "code": "688321"
  },
  {
    "title": "微芯生物：全资子公司获得临床试验",
    "href": "http://stock.jrj.com.cn/2021/05/31163032850533.shtml",
    "datetime": "2021-05-31 16:30:48",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：1类新药西格列他钠获批临床",
    "href": "http://stock.jrj.com.cn/2021/05/31160632850079.shtml",
    "datetime": "2021-05-31 16:06:13",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：72.05万股限制性股票符合归属条件",
    "href": "http://stock.jrj.com.cn/2021/05/28171032835833.shtml",
    "datetime": "2021-05-28 17:10:55",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：LAV One方面4月22日以来减持1.02%股份",
    "href": "http://stock.jrj.com.cn/2021/05/21155932793492.shtml",
    "datetime": "2021-05-21 15:59:40",
    "code": "688321"
  },
  {
    "title": "微芯生物：一季度营收环比去年第四季度略有下降主要是一季度春节假期的影响",
    "href": "http://stock.jrj.com.cn/2021/05/10164832730199.shtml",
    "datetime": "2021-05-10 16:48:36",
    "code": "688321"
  },
  {
    "title": "微芯生物：目前公司在抗病毒领域领域正在进行前期研究",
    "href": "http://stock.jrj.com.cn/2021/05/10164832730198.shtml",
    "datetime": "2021-05-10 16:48:25",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司预计对西奥罗尼美国临床试验阶段性投资约为2237万美元",
    "href": "http://stock.jrj.com.cn/2021/05/10164832730197.shtml",
    "datetime": "2021-05-10 16:48:08",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司西达本胺2021年第一季度的销售量75,304,640.64元同比增长130.06%",
    "href": "http://stock.jrj.com.cn/2021/05/10164832730200.shtml",
    "datetime": "2021-05-10 16:48:07",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司的PD-1/L1 抑制剂临床前研究进展正在进行中",
    "href": "http://stock.jrj.com.cn/2021/05/10164632730188.shtml",
    "datetime": "2021-05-10 16:46:49",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/05/06205032703285.shtml",
    "datetime": "2021-05-06 20:50:56",
    "code": "688321"
  },
  {
    "title": "微芯生物：LAVOne及一致行动人持股比例从11%减少至9.98%",
    "href": "http://stock.jrj.com.cn/2021/04/22181632424714.shtml",
    "datetime": "2021-04-22 18:16:44",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西达本胺片的临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/04/19172932402871.shtml",
    "datetime": "2021-04-19 17:29:30",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼治疗复发/难治性SCLC获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/04/16161832386824.shtml",
    "datetime": "2021-04-16 16:18:23",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321)：西奥罗尼胶囊获得《药物临床试验批准通知书》",
    "href": "http://stock.jrj.com.cn/2021/04/15200432381645.shtml",
    "datetime": "2021-04-15 20:04:08",
    "code": "688321"
  },
  {
    "title": "微芯生物2020年净利增长59.85% 董事长XIANPING LU薪酬347.3万",
    "href": "http://stock.jrj.com.cn/2021/03/31215532258653.shtml",
    "datetime": "2021-03-31 21:55:08",
    "code": "688321"
  },
  {
    "title": "微芯生物预计2021年拟继续加大研发投入不进行派现 拟斥资不超过1.88亿回购",
    "href": "http://stock.jrj.com.cn/2021/03/31100432254061.shtml",
    "datetime": "2021-03-31 10:04:08",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)2020年度净利润升59.85%至3104.6万元",
    "href": "http://stock.jrj.com.cn/2021/03/30214432249860.shtml",
    "datetime": "2021-03-30 21:44:20",
    "code": "688321"
  },
  {
    "title": "微芯生物：我们公司按照国内和欧美的标准 都属first in class",
    "href": "http://stock.jrj.com.cn/2021/03/25132032215012.shtml",
    "datetime": "2021-03-25 13:20:44",
    "code": "688321"
  },
  {
    "title": "微芯生物：西格列他钠现场生产核查工作已经安排完成",
    "href": "http://stock.jrj.com.cn/2021/03/25131732214993.shtml",
    "datetime": "2021-03-25 13:17:38",
    "code": "688321"
  },
  {
    "title": "微芯生物：成都微芯西格列他钠片临床试验获受理",
    "href": "http://stock.jrj.com.cn/2021/03/24110232207265.shtml",
    "datetime": "2021-03-24 11:02:03",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西格列他钠治疗非酒精性脂肪肝II期临床试验获受理",
    "href": "http://stock.jrj.com.cn/2021/03/23182832202937.shtml",
    "datetime": "2021-03-23 18:28:01",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼胶囊新药临床试验申请获FDA受理",
    "href": "http://stock.jrj.com.cn/2021/03/18182532158498.shtml",
    "datetime": "2021-03-18 18:25:15",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼胶囊获准开展临床试验",
    "href": "http://stock.jrj.com.cn/2021/03/18102532155823.shtml",
    "datetime": "2021-03-18 10:25:59",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼胶囊获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/03/17174532151973.shtml",
    "datetime": "2021-03-17 17:45:55",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼胶囊被纳入拟突破性治疗品种公示名单",
    "href": "http://stock.jrj.com.cn/2021/03/17094532149583.shtml",
    "datetime": "2021-03-17 09:45:04",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼胶囊纳入拟突破性治疗品种公示",
    "href": "http://stock.jrj.com.cn/2021/03/16183432146458.shtml",
    "datetime": "2021-03-16 18:34:13",
    "code": "688321"
  },
  {
    "title": "微芯生物股东萍乡永智减持1362.03万股 套现6.04亿",
    "href": "http://stock.jrj.com.cn/2021/03/05194532079862.shtml",
    "datetime": "2021-03-05 19:45:47",
    "code": "688321"
  },
  {
    "title": "微芯生物：萍乡永智共计减持1362.02万股 占公司总股本3.32%",
    "href": "http://stock.jrj.com.cn/2021/03/05175232079252.shtml",
    "datetime": "2021-03-05 17:52:07",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：萍乡永智减持期届满 累计减持1362.03万股",
    "href": "http://stock.jrj.com.cn/2021/03/05162732078542.shtml",
    "datetime": "2021-03-05 16:27:34",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司成都研发中心已完成入驻 大分子研发团队也已就位",
    "href": "http://stock.jrj.com.cn/2021/03/04181632072111.shtml",
    "datetime": "2021-03-04 18:16:14",
    "code": "688321"
  },
  {
    "title": "微芯生物2020年度净利3104.6万增长59.85% 西达本胺产品销售开始放量增长",
    "href": "http://stock.jrj.com.cn/2021/02/27111232037892.shtml",
    "datetime": "2021-02-27 11:12:51",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)业绩快报：2020年净利升59.85%至3104.60万元",
    "href": "http://stock.jrj.com.cn/2021/02/26160932033151.shtml",
    "datetime": "2021-02-26 16:09:22",
    "code": "688321"
  },
  {
    "title": "微芯生物：股东LAV One及一致行动人减持比例达1%",
    "href": "http://stock.jrj.com.cn/2021/02/23105232011280.shtml",
    "datetime": "2021-02-23 10:52:46",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：股东LAV One及一致行动人Vertex减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/02/22175132006886.shtml",
    "datetime": "2021-02-22 17:51:16",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼胶囊新药临床试验申请获药监局受理",
    "href": "http://stock.jrj.com.cn/2021/02/10104431882012.shtml",
    "datetime": "2021-02-10 10:44:52",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼胶囊获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/02/09161331877611.shtml",
    "datetime": "2021-02-09 16:13:37",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司目前进展较快的在研产品有西达本胺、西格列他钠、西奥罗尼、CS12192",
    "href": "http://stock.jrj.com.cn/2021/02/03182831844548.shtml",
    "datetime": "2021-02-03 18:28:28",
    "code": "688321"
  },
  {
    "title": "微芯生物：西达本胺填补了国内外周T细胞淋巴瘤的治疗空白",
    "href": "http://stock.jrj.com.cn/2021/01/29140931808825.shtml",
    "datetime": "2021-01-29 14:09:39",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司目前己形成了30个在研项目涉及14个候选新分子实体药物的可持续发展在研产品线",
    "href": "http://stock.jrj.com.cn/2021/01/29140931808826.shtml",
    "datetime": "2021-01-29 14:09:33",
    "code": "688321"
  },
  {
    "title": "微芯生物：2020年扣非净利润预减超550.10万元",
    "href": "http://stock.jrj.com.cn/2021/01/29110631807694.shtml",
    "datetime": "2021-01-29 11:06:47",
    "code": "688321"
  },
  {
    "title": "微芯生物2020年预计净利2719.06万-3107.5万增加40%-60% 西达本胺产品销售增长",
    "href": "http://stock.jrj.com.cn/2021/01/28183631802314.shtml",
    "datetime": "2021-01-28 18:36:14",
    "code": "688321"
  },
  {
    "title": "微芯生物：截止目前为止 公司的股权结构稳定 实控人以及一致行动人没有发生变化",
    "href": "http://stock.jrj.com.cn/2021/01/14121731690196.shtml",
    "datetime": "2021-01-14 12:17:25",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼胶囊新药临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/01/11104031668803.shtml",
    "datetime": "2021-01-11 10:40:08",
    "code": "688321"
  },
  {
    "title": "[微芯生物]微芯生物抗肿瘤原创新药西奥罗尼治疗小细胞肺癌关键性Ⅲ期临床试验申请(IND)获受理",
    "href": "http://stock.jrj.com.cn/2021/01/11000031680885.shtml",
    "datetime": "2021-01-11 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：西奥罗尼肝癌适应症正在进行1b/2a 期临床试验",
    "href": "http://stock.jrj.com.cn/2021/01/08164431655884.shtml",
    "datetime": "2021-01-08 16:44:08",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：西奥罗尼胶囊临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/01/08164331655869.shtml",
    "datetime": "2021-01-08 16:43:35",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)子公司收到西格列他钠注册现场检查通知",
    "href": "http://stock.jrj.com.cn/2021/01/06165231642080.shtml",
    "datetime": "2021-01-06 16:52:17",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：拟购买深圳南山智谷产业园B座21层至24层研发及办公场地",
    "href": "http://stock.jrj.com.cn/2020/12/28182231587399.shtml",
    "datetime": "2020-12-28 18:22:53",
    "code": "688321"
  },
  {
    "title": "微芯生物：目前公司肿瘤药的营销全部由公司自建团队实施",
    "href": "http://stock.jrj.com.cn/2020/12/21143331535904.shtml",
    "datetime": "2020-12-21 14:33:23",
    "code": "688321"
  },
  {
    "title": "“药”闻|微芯生物：西奥罗尼胶囊被纳入拟突破性治疗品种公示名单",
    "href": "http://stock.jrj.com.cn/2020/12/21103131534445.shtml",
    "datetime": "2020-12-21 10:31:52",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：将西格列他钠中国大陆指定区域市场推广权益独家许可给海正药业",
    "href": "http://stock.jrj.com.cn/2020/12/16174131503239.shtml",
    "datetime": "2020-12-16 17:41:55",
    "code": "688321"
  },
  {
    "title": "[微芯生物]微芯生物与海正药业达成战略合作",
    "href": "http://stock.jrj.com.cn/2020/12/16000031507935.shtml",
    "datetime": "2020-12-16 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：股东减持股票放量大跌 费用拖累下持续增收不增利",
    "href": "http://stock.jrj.com.cn/kcb/2020/12/11073331462274.shtml",
    "datetime": "2020-12-11 07:33:15",
    "code": "688321"
  },
  {
    "title": "微芯生物跌近12% 在国海证券平安证券唱多声中下跌",
    "href": "http://stock.jrj.com.cn/2020/12/08173731441302.shtml",
    "datetime": "2020-12-08 17:37:00",
    "code": "688321"
  },
  {
    "title": "A股异动丨微芯生物(688321.SH)大跌近11% 两股东拟减持公司不超6%股份",
    "href": "http://stock.jrj.com.cn/2020/12/08132531439093.shtml",
    "datetime": "2020-12-08 13:25:56",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：LAV One及Vertex拟减持合计不超6%股份",
    "href": "http://stock.jrj.com.cn/2020/12/07161631430802.shtml",
    "datetime": "2020-12-07 16:16:33",
    "code": "688321"
  },
  {
    "title": "微芯生物股东Vertex减持324.79万股 套现约1.51亿元",
    "href": "http://stock.jrj.com.cn/2020/12/04214831411037.shtml",
    "datetime": "2020-12-04 21:48:46",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：萍乡永智减持期过半 累计减持1.9078%",
    "href": "http://stock.jrj.com.cn/2020/12/04185631409813.shtml",
    "datetime": "2020-12-04 18:56:02",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：两名股东减持期届满 仅Vertex减持324.79万股",
    "href": "http://stock.jrj.com.cn/2020/12/04185531409814.shtml",
    "datetime": "2020-12-04 18:55:59",
    "code": "688321"
  },
  {
    "title": "微芯生物：以高质量的原创新药和良好的成长规模回报患者和投资者",
    "href": "http://stock.jrj.com.cn/2020/11/02181731201938.shtml",
    "datetime": "2020-11-02 18:17:57",
    "code": "688321"
  },
  {
    "title": "微芯生物：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/28001031145369.shtml",
    "datetime": "2020-10-28 00:10:14",
    "code": "688321"
  },
  {
    "title": "微芯生物前三季度净利3842.68万增长84.48% 西达本胺销量增",
    "href": "http://stock.jrj.com.cn/2020/10/27192731143778.shtml",
    "datetime": "2020-10-27 19:27:58",
    "code": "688321"
  },
  {
    "title": "微芯生物收监管工作函 上交所就股东减持提监管要求",
    "href": "http://stock.jrj.com.cn/2020/10/14144331051528.shtml",
    "datetime": "2020-10-14 14:43:00",
    "code": "688321"
  },
  {
    "title": "微芯生物(688321.SH)：萍乡永智减持192.21万股 持股跌出5%",
    "href": "http://stock.jrj.com.cn/2020/10/13171331044411.shtml",
    "datetime": "2020-10-13 17:13:07",
    "code": "688321"
  },
  {
    "title": "[微芯生物]西达本胺在日本递交首个适应症新药上市申请并获受理",
    "href": "http://stock.jrj.com.cn/2020/10/13000031092400.shtml",
    "datetime": "2020-10-13 00:00:00",
    "code": "688321"
  },
  {
    "title": "[微芯生物]西达本胺专利布局再下一城:乳腺癌适应症中国发明专利获授权",
    "href": "http://stock.jrj.com.cn/2020/10/10000031059703.shtml",
    "datetime": "2020-10-10 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：现阶段会根据公司关注的重点治疗领域包括肿瘤与自身免疫性疾病等",
    "href": "http://stock.jrj.com.cn/2020/09/21180530803676.shtml",
    "datetime": "2020-09-21 18:05:07",
    "code": "688321"
  },
  {
    "title": "[微芯生物]微芯生物荣获2020中国医药工业信息中心颁发“中国医药新锐创新力量”称号",
    "href": "http://stock.jrj.com.cn/2020/09/01000031534516.shtml",
    "datetime": "2020-09-01 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：股东拟合计减持不超过公司总股本的9.91%股份",
    "href": "http://stock.jrj.com.cn/2020/08/13200130493392.shtml",
    "datetime": "2020-08-13 20:01:29",
    "code": "688321"
  },
  {
    "title": "天量解禁又酿“血案”：曾创A股纪录的牛股断崖式暴跌",
    "href": "http://stock.jrj.com.cn/2020/08/13065330487573.shtml",
    "datetime": "2020-08-13 06:53:46",
    "code": "688321"
  },
  {
    "title": "天量解禁又酿“血案”：曾创A股纪录的大牛股断崖式暴跌",
    "href": "http://stock.jrj.com.cn/2020/08/12184730484014.shtml",
    "datetime": "2020-08-12 18:47:00",
    "code": "688321"
  },
  {
    "title": "微芯生物年内涨幅23%！下周2亿股天量解禁",
    "href": "http://stock.jrj.com.cn/2020/08/03190430414800.shtml",
    "datetime": "2020-08-03 19:04:02",
    "code": "688321"
  },
  {
    "title": "微芯生物2020年上半年净利2871.17万增长64% 加大研发投入",
    "href": "http://stock.jrj.com.cn/2020/07/27205830357156.shtml",
    "datetime": "2020-07-27 20:58:36",
    "code": "688321"
  },
  {
    "title": "微芯生物上半年净利同比增长64%",
    "href": "http://stock.jrj.com.cn/2020/07/27193530356805.shtml",
    "datetime": "2020-07-27 19:35:46",
    "code": "688321"
  },
  {
    "title": "微芯生物半年报：上半年净利润同比增长64%",
    "href": "http://stock.jrj.com.cn/2020/07/27180830356367.shtml",
    "datetime": "2020-07-27 18:08:42",
    "code": "688321"
  },
  {
    "title": "微芯生物CS12192胶囊获临试通知",
    "href": "http://stock.jrj.com.cn/2020/06/04215629846788.shtml",
    "datetime": "2020-06-04 21:56:16",
    "code": "688321"
  },
  {
    "title": "微芯生物：第一届董事会第十五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/28003029782161.shtml",
    "datetime": "2020-05-28 00:30:05",
    "code": "688321"
  },
  {
    "title": "[微芯生物]西达本胺弥漫大B细胞淋巴瘤Ⅲ期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2020/05/22000031059702.shtml",
    "datetime": "2020-05-22 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/17191029691630.shtml",
    "datetime": "2020-05-17 19:10:00",
    "code": "688321"
  },
  {
    "title": "微芯生物2020年第一季度盈利519.23万增长251.14% 其他收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/05/01142929440101.shtml",
    "datetime": "2020-05-01 14:29:41",
    "code": "688321"
  },
  {
    "title": "微芯生物：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405117.shtml",
    "datetime": "2020-04-28 15:50:18",
    "code": "688321"
  },
  {
    "title": "微芯生物上市年净利大降38% 投行安信证券赚6129万",
    "href": "http://stock.jrj.com.cn/2020/04/22065229344575.shtml",
    "datetime": "2020-04-22 06:52:00",
    "code": "688321"
  },
  {
    "title": "微芯生物聘任潘德思为副总经理 2019年薪酬66万元",
    "href": "http://stock.jrj.com.cn/2020/04/21180529339754.shtml",
    "datetime": "2020-04-21 18:05:05",
    "code": "688321"
  },
  {
    "title": "微芯生物：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/21031029332960.shtml",
    "datetime": "2020-04-21 03:10:02",
    "code": "688321"
  },
  {
    "title": "微芯生物：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/21031029332959.shtml",
    "datetime": "2020-04-21 03:10:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：第一届董事会第十三次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/21031029332957.shtml",
    "datetime": "2020-04-21 03:10:00",
    "code": "688321"
  },
  {
    "title": "微芯生物CS12192临床试验申请获受理 系治疗自身免疫相关性疾病原创新药",
    "href": "http://stock.jrj.com.cn/2020/03/25112029104135.shtml",
    "datetime": "2020-03-25 11:20:00",
    "code": "688321"
  },
  {
    "title": "微芯生物治疗自身免疫相关性疾病原创新药临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/03/25105629104002.shtml",
    "datetime": "2020-03-25 10:56:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：CS12192临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/03/24191529096515.shtml",
    "datetime": "2020-03-24 19:15:37",
    "code": "688321"
  },
  {
    "title": "微芯生物：CS12192临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2020/03/24190829096486.shtml",
    "datetime": "2020-03-24 19:08:00",
    "code": "688321"
  },
  {
    "title": "[微芯生物]微芯生物治疗自身免疫相关性疾病原创新药CS12192临床试验申请(IND)获得受理",
    "href": "http://stock.jrj.com.cn/2020/03/24000031059701.shtml",
    "datetime": "2020-03-24 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物2019年度盈利1946.54万减少38% 研发费和销售费增长",
    "href": "http://stock.jrj.com.cn/2020/02/26211828899659.shtml",
    "datetime": "2020-02-26 21:18:11",
    "code": "688321"
  },
  {
    "title": "微芯生物业绩快报：2019年净利同比下降37.54%",
    "href": "http://stock.jrj.com.cn/2020/02/26193528899182.shtml",
    "datetime": "2020-02-26 19:35:10",
    "code": "688321"
  },
  {
    "title": "微芯生物业绩快报：2019年净利1946.54万元 同比下降37.54％",
    "href": "http://stock.jrj.com.cn/2020/02/26183528898506.shtml",
    "datetime": "2020-02-26 18:35:19",
    "code": "688321"
  },
  {
    "title": "微芯生物：首次公开发行网下配售限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2020/02/03225028758342.shtml",
    "datetime": "2020-02-03 22:50:02",
    "code": "688321"
  },
  {
    "title": "[微芯生物]“专注创新 共同筑梦”——微芯生物2019年会在深圳圆满召开",
    "href": "http://stock.jrj.com.cn/2020/01/19000031059704.shtml",
    "datetime": "2020-01-19 00:00:00",
    "code": "688321"
  },
  {
    "title": "[微芯生物]微芯生物董事长鲁先平荣获深圳市科学技术奖市长奖——根植创新沃土 成就原创新药",
    "href": "http://stock.jrj.com.cn/2020/01/03000031059700.shtml",
    "datetime": "2020-01-03 00:00:00",
    "code": "688321"
  },
  {
    "title": "[微芯生物]原创新药西达本胺(爱谱沙)乳腺癌新适应症正式获批上市",
    "href": "http://stock.jrj.com.cn/2019/12/03000031059699.shtml",
    "datetime": "2019-12-03 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：获得西达本胺片药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/11/29200428470264.shtml",
    "datetime": "2019-11-29 20:04:00",
    "code": "688321"
  },
  {
    "title": "微芯生物获得西达本胺片药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/11/29194728470232.shtml",
    "datetime": "2019-11-29 19:47:45",
    "code": "688321"
  },
  {
    "title": "微芯生物：西达本胺片获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/11/29184528469893.shtml",
    "datetime": "2019-11-29 18:45:25",
    "code": "688321"
  },
  {
    "title": "微芯生物西达本胺续约进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28173628464400.shtml",
    "datetime": "2019-11-28 17:36:36",
    "code": "688321"
  },
  {
    "title": "微芯生物：西达本胺续约进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28165328463772.shtml",
    "datetime": "2019-11-28 16:53:51",
    "code": "688321"
  },
  {
    "title": "微芯生物：公司产品西达本胺续约进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28164928463763.shtml",
    "datetime": "2019-11-28 16:49:58",
    "code": "688321"
  },
  {
    "title": "[微芯生物]国家科技部秘书长苗少波一行调研微芯生物 倾听企业心声",
    "href": "http://stock.jrj.com.cn/2019/11/19000031059698.shtml",
    "datetime": "2019-11-19 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：专注原创新药 希望有机会进入到国际市场",
    "href": "http://stock.jrj.com.cn/2019/11/12144928388076.shtml",
    "datetime": "2019-11-12 14:49:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：明后年都会有新药进入临床申请",
    "href": "http://stock.jrj.com.cn/2019/11/12144628388075.shtml",
    "datetime": "2019-11-12 14:46:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：科创板引导企业从追求利润走向技术创新 将加大投入研发",
    "href": "http://stock.jrj.com.cn/2019/11/12144028388039.shtml",
    "datetime": "2019-11-12 14:40:00",
    "code": "688321"
  },
  {
    "title": "【高管面对面】微芯生物：为中国患者研发价格适宜的原创新药",
    "href": "http://stock.jrj.com.cn/2019/11/12135328387530.shtml",
    "datetime": "2019-11-12 13:53:00",
    "code": "688321"
  },
  {
    "title": "[微芯生物]国家卫健委医药卫生科技发展研究中心赴微芯生物调研",
    "href": "http://stock.jrj.com.cn/2019/11/05000031059697.shtml",
    "datetime": "2019-11-05 00:00:00",
    "code": "688321"
  },
  {
    "title": "微芯生物前三季度盈利2083万 同比增长38%",
    "href": "http://stock.jrj.com.cn/2019/10/31220528335410.shtml",
    "datetime": "2019-10-31 22:05:59",
    "code": "688321"
  },
  {
    "title": "微芯生物：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/30014028321504.shtml",
    "datetime": "2019-10-30 01:40:23",
    "code": "688321"
  },
  {
    "title": "微芯生物前三季净利增长38%",
    "href": "http://stock.jrj.com.cn/2019/10/29231528320797.shtml",
    "datetime": "2019-10-29 23:15:08",
    "code": "688321"
  },
  {
    "title": "数据复盘｜微芯生物涨停主力资金净买入逾亿元 机构资金加仓这4股",
    "href": "http://stock.jrj.com.cn/invest/2019/10/23191328289641.shtml",
    "datetime": "2019-10-23 19:13:00",
    "code": "688321"
  },
  {
    "title": "午后科创板个股集体走强 微芯生物率先涨停",
    "href": "http://stock.jrj.com.cn/2019/10/23141628287778.shtml",
    "datetime": "2019-10-23 14:16:10",
    "code": "688321"
  },
  {
    "title": "午后科创板个股集体走强 微芯生物拉升涨逾15％",
    "href": "http://stock.jrj.com.cn/2019/10/23141228287774.shtml",
    "datetime": "2019-10-23 14:12:01",
    "code": "688321"
  },
  {
    "title": "[微芯生物]微芯生物与诺禾致源签署肿瘤新药伴随诊断产品合作开发协议",
    "href": "http://stock.jrj.com.cn/2019/10/09000031059696.shtml",
    "datetime": "2019-10-09 00:00:00",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物：与诺禾致源签署伴随诊断产品开发合作框架协议",
    "href": "http://stock.jrj.com.cn/2019/10/08205628215127.shtml",
    "datetime": "2019-10-08 20:56:21",
    "code": "688321"
  },
  {
    "title": "小甜甜秒变牛夫人！科创板一天出现两只腰斩股 机构：别忙着抄底",
    "href": "http://stock.jrj.com.cn/kcb/2019/09/26151228184614.shtml",
    "datetime": "2019-09-26 15:12:02",
    "code": "688321"
  },
  {
    "title": "科创板腰斩第二股诞生！微芯生物较上市首日高点累跌近51%",
    "href": "http://stock.jrj.com.cn/kcb/2019/09/26113128183747.shtml",
    "datetime": "2019-09-26 11:31:07",
    "code": "688321"
  },
  {
    "title": "微芯生物收到药品注册受理通知书",
    "href": "http://stock.jrj.com.cn/2019/09/20152228160447.shtml",
    "datetime": "2019-09-20 15:22:06",
    "code": "688321"
  },
  {
    "title": "微芯生物重磅新药西格列他钠 上市申请获受理",
    "href": "http://stock.jrj.com.cn/2019/09/19230328155931.shtml",
    "datetime": "2019-09-19 23:03:00",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物：西达本胺片获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/08/29213428057918.shtml",
    "datetime": "2019-08-29 21:34:14",
    "code": "688321"
  },
  {
    "title": "微芯生物上市首日创纪录 医药板块跟风上涨",
    "href": "http://stock.jrj.com.cn/2019/08/15025627978180.shtml",
    "datetime": "2019-08-15 02:56:42",
    "code": "688321"
  },
  {
    "title": "微芯生物千倍市盈率惊呆了A股 为何给低了预估股价？",
    "href": "http://stock.jrj.com.cn/2019/08/14200227977174.shtml",
    "datetime": "2019-08-14 20:02:21",
    "code": "688321"
  },
  {
    "title": "医药股集体走强：康龙化成等6股涨停 科创板微芯生物大涨17%",
    "href": "http://stock.jrj.com.cn/2019/08/14142427975318.shtml",
    "datetime": "2019-08-14 14:24:06",
    "code": "688321"
  },
  {
    "title": "科创板个股涨幅扩大 微芯生物涨超11%",
    "href": "http://stock.jrj.com.cn/2019/08/14102527974231.shtml",
    "datetime": "2019-08-14 10:25:00",
    "code": "688321"
  },
  {
    "title": "融券利率最高飙至60% 谁在“抢卖”微芯生物？",
    "href": "http://stock.jrj.com.cn/2019/08/14014227971975.shtml",
    "datetime": "2019-08-14 01:42:25",
    "code": "688321"
  },
  {
    "title": "微芯生物融券利率最高年化达60%",
    "href": "http://stock.jrj.com.cn/2019/08/13120727969005.shtml",
    "datetime": "2019-08-13 12:07:00",
    "code": "688321"
  },
  {
    "title": "科创板融券利率最高年化达60%！谁在\"抢卖\"微芯生物",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/13120427968996.shtml",
    "datetime": "2019-08-13 12:04:42",
    "code": "688321"
  },
  {
    "title": "开盘暴涨逾500%！科创板“创新药第一股”微芯生物魅力在哪？",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/13072127967679.shtml",
    "datetime": "2019-08-13 07:21:52",
    "code": "688321"
  },
  {
    "title": "最高暴赚280倍！明星VC赚大了",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/13071627967632.shtml",
    "datetime": "2019-08-13 07:16:22",
    "code": "688321"
  },
  {
    "title": "微芯生物开盘涨5倍 盲目追高风险大",
    "href": "http://stock.jrj.com.cn/2019/08/13063727965380.shtml",
    "datetime": "2019-08-13 06:37:00",
    "code": "688321"
  },
  {
    "title": "8月13日三大证券报精华摘要",
    "href": "http://stock.jrj.com.cn/2019/08/13025327965004.shtml",
    "datetime": "2019-08-13 02:53:53",
    "code": "688321"
  },
  {
    "title": "微芯生物上市首日抢眼 后续科创板同领域企业表现或分化",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/13023427964981.shtml",
    "datetime": "2019-08-13 02:34:31",
    "code": "688321"
  },
  {
    "title": "刷新科创板估值水平 微芯生物动态市盈率逾千倍",
    "href": "http://stock.jrj.com.cn/2019/08/13021927964955.shtml",
    "datetime": "2019-08-13 02:19:34",
    "code": "688321"
  },
  {
    "title": "开盘涨5倍 微芯生物拿什么支撑390亿市值",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/13005127964724.shtml",
    "datetime": "2019-08-13 00:51:28",
    "code": "688321"
  },
  {
    "title": "微芯生物上市首日大涨366.5% 刷新多项科创板纪录",
    "href": "http://stock.jrj.com.cn/2019/08/12194827963917.shtml",
    "datetime": "2019-08-12 19:48:04",
    "code": "688321"
  },
  {
    "title": "微芯生物刷新科创板开盘涨幅纪录 有机构人士表示已抛售",
    "href": "http://stock.jrj.com.cn/2019/08/12131127961897.shtml",
    "datetime": "2019-08-12 13:11:00",
    "code": "688321"
  },
  {
    "title": "科创板新纪录！微芯生物开盘涨逾5倍 市盈率一度飙至逾2000倍",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/12120927961756.shtml",
    "datetime": "2019-08-12 12:09:52",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物今日上市 高开511.8%",
    "href": "http://stock.jrj.com.cn/2019/08/12093027960930.shtml",
    "datetime": "2019-08-12 09:30:00",
    "code": "688321"
  },
  {
    "title": "微芯生物科创板上市 暴涨511.85%市盈率1463倍",
    "href": "http://stock.jrj.com.cn/2019/08/12092527960842.shtml",
    "datetime": "2019-08-12 09:25:44",
    "code": "688321"
  },
  {
    "title": "微芯生物今日科创板上市 467倍PE刷新科创板首发记录",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/12080827960625.shtml",
    "datetime": "2019-08-12 08:08:02",
    "code": "688321"
  },
  {
    "title": "微芯生物下周一将登陆科创板",
    "href": "http://stock.jrj.com.cn/2019/08/08211727949201.shtml",
    "datetime": "2019-08-08 21:17:00",
    "code": "688321"
  },
  {
    "title": "微芯生物：8月12日上交所科创板上市",
    "href": "http://stock.jrj.com.cn/2019/08/08191927948824.shtml",
    "datetime": "2019-08-08 19:19:00",
    "code": "688321"
  },
  {
    "title": "微芯生物8月12日在科创板上市",
    "href": "http://stock.jrj.com.cn/2019/08/08124027946870.shtml",
    "datetime": "2019-08-08 12:40:24",
    "code": "688321"
  },
  {
    "title": "深圳微芯生物科技股份有限公司首次公开发行股票并在科创板上市发行结果公告",
    "href": "http://stock.jrj.com.cn/2019/08/06144527944647.shtml",
    "datetime": "2019-08-06 14:45:00",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物：15458股遭投资者弃购 由主承销商包销",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/05212827932076.shtml",
    "datetime": "2019-08-05 21:28:34",
    "code": "688321"
  },
  {
    "title": "微芯生物发行结果：网上投资者弃购31.58万元",
    "href": "http://stock.jrj.com.cn/2019/08/05193227931771.shtml",
    "datetime": "2019-08-05 19:32:00",
    "code": "688321"
  },
  {
    "title": "微芯生物中签结果出炉：高管认购1亿元公司股票",
    "href": "http://stock.jrj.com.cn/2019/08/02111727920480.shtml",
    "datetime": "2019-08-02 11:17:58",
    "code": "688321"
  },
  {
    "title": "8月2日新股提示：苏州银行上市 微芯生物、海星股份中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2019/08/02081927920355.shtml",
    "datetime": "2019-08-02 08:19:19",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物网上申购中签号出炉 共25600个",
    "href": "http://stock.jrj.com.cn/ipo/2019/08/01193427917031.shtml",
    "datetime": "2019-08-01 19:34:02",
    "code": "688321"
  },
  {
    "title": "8月1日新股提示：青鸟消防中签号出炉 微芯生物、海星股份公布中签率",
    "href": "http://stock.jrj.com.cn/ipo/2019/08/01082527919296.shtml",
    "datetime": "2019-08-01 08:25:35",
    "code": "688321"
  },
  {
    "title": "微芯生物网上发行最终中签率为0.051%",
    "href": "http://stock.jrj.com.cn/ipo/2019/08/01081727914734.shtml",
    "datetime": "2019-08-01 08:17:24",
    "code": "688321"
  },
  {
    "title": "海星股份：网上发行最终中签率为0.03997341％",
    "href": "http://stock.jrj.com.cn/ipo/2019/07/31194727909947.shtml",
    "datetime": "2019-07-31 19:47:23",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物：网上发行最终中签率为0.05093890％",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/31194627909934.shtml",
    "datetime": "2019-07-31 19:46:06",
    "code": "688321"
  },
  {
    "title": "深圳微芯生物科技股份有限公司首次公开发行股票并在科创板上市网上申购情况及中签率公告",
    "href": "http://stock.jrj.com.cn/2019/07/31192027924407.shtml",
    "datetime": "2019-07-31 19:20:00",
    "code": "688321"
  },
  {
    "title": "微芯生物今日申购：发行价20.43元 发行市值为83.763 亿元",
    "href": "http://stock.jrj.com.cn/2019/07/31094627907474.shtml",
    "datetime": "2019-07-31 09:46:09",
    "code": "688321"
  },
  {
    "title": "7月31日新股提示：微芯生物、海星股份申购 晶晨股份、柏楚电子中签号出炉 青鸟消防公布中签率",
    "href": "http://stock.jrj.com.cn/ipo/2019/07/31082927913832.shtml",
    "datetime": "2019-07-31 08:29:09",
    "code": "688321"
  },
  {
    "title": "微芯生物今日申购 顶格申购需配市值8.5万元",
    "href": "http://stock.jrj.com.cn/ipo/2019/07/31081027911159.shtml",
    "datetime": "2019-07-31 08:10:32",
    "code": "688321"
  },
  {
    "title": "新股提示：微芯生物、海星股份今日申购",
    "href": "http://stock.jrj.com.cn/2019/07/31070427906640.shtml",
    "datetime": "2019-07-31 07:04:00",
    "code": "688321"
  },
  {
    "title": "科创板新股微芯生物7月31日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/30142427903672.shtml",
    "datetime": "2019-07-30 14:24:57",
    "code": "688321"
  },
  {
    "title": "微芯生物发行市盈率创新高！网上申购者增10万户券商躺赢20亿",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/30102227902656.shtml",
    "datetime": "2019-07-30 10:22:22",
    "code": "688321"
  },
  {
    "title": "微芯生物7月31日申购 发行价20.43元/股",
    "href": "http://stock.jrj.com.cn/2019/07/29235827901074.shtml",
    "datetime": "2019-07-29 23:58:00",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物：发行价确定为20.43元/股",
    "href": "http://stock.jrj.com.cn/2019/07/29221127900905.shtml",
    "datetime": "2019-07-29 22:11:00",
    "code": "688321"
  },
  {
    "title": "深圳微芯生物科技股份有限公司首次公开发行股票并在科创板上市网上路演公告",
    "href": "http://stock.jrj.com.cn/2019/07/29160127924398.shtml",
    "datetime": "2019-07-29 16:01:00",
    "code": "688321"
  },
  {
    "title": "微芯生物拟于7月30日举行网上路演",
    "href": "http://stock.jrj.com.cn/2019/07/28152027895562.shtml",
    "datetime": "2019-07-28 15:20:00",
    "code": "688321"
  },
  {
    "title": "正式回应研发费用资本化问题 微芯生物：将予以费用化调整",
    "href": "http://stock.jrj.com.cn/2019/07/23200527877990.shtml",
    "datetime": "2019-07-23 20:05:35",
    "code": "688321"
  },
  {
    "title": "微芯生物最新反馈意见回复：按谨慎性原则更正会计差错",
    "href": "http://stock.jrj.com.cn/2019/07/23132327876255.shtml",
    "datetime": "2019-07-23 13:23:29",
    "code": "688321"
  },
  {
    "title": "每经小强快讯：深圳微芯生物科技股份有限公司关于发行注册环节相关意见落实函的回复",
    "href": "http://stock.jrj.com.cn/2019/07/22203927872117.shtml",
    "datetime": "2019-07-22 20:39:07",
    "code": "688321"
  },
  {
    "title": "每经小强快讯：深圳微芯生物科技股份有限公司及安信证券股份有限公司关于发行注册环节反馈意见落实函的回复",
    "href": "http://stock.jrj.com.cn/2019/07/22203927872119.shtml",
    "datetime": "2019-07-22 20:39:07",
    "code": "688321"
  },
  {
    "title": "每经小强快讯：深圳微芯生物科技股份有限公司科创板首次公开发行股票招股说明书（注册稿）",
    "href": "http://stock.jrj.com.cn/2019/07/22202927872116.shtml",
    "datetime": "2019-07-22 20:29:18",
    "code": "688321"
  },
  {
    "title": "好事多磨 微芯生物7月31网上申购",
    "href": "http://stock.jrj.com.cn/2019/07/21234327867524.shtml",
    "datetime": "2019-07-21 23:43:00",
    "code": "688321"
  },
  {
    "title": "“688321”微芯生物将于7月23日启动网下路演",
    "href": "http://stock.jrj.com.cn/2019/07/21201727867302.shtml",
    "datetime": "2019-07-21 20:17:39",
    "code": "688321"
  },
  {
    "title": "科创板微芯生物：初步询价时间为7月26日",
    "href": "http://stock.jrj.com.cn/2019/07/21193327867258.shtml",
    "datetime": "2019-07-21 19:33:00",
    "code": "688321"
  },
  {
    "title": "微芯生物获准注册 研发支出资本化引热议",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/19045827859744.shtml",
    "datetime": "2019-07-19 04:58:34",
    "code": "688321"
  },
  {
    "title": "问出真公司：微芯生物历时36天注册终生效",
    "href": "http://stock.jrj.com.cn/2019/07/18102027856118.shtml",
    "datetime": "2019-07-18 10:20:10",
    "code": "688321"
  },
  {
    "title": "微芯生物IPO注册生效 彰显科创板法治化精神",
    "href": "http://stock.jrj.com.cn/2019/07/18080527855314.shtml",
    "datetime": "2019-07-18 08:05:27",
    "code": "688321"
  },
  {
    "title": "微芯生物终拿科创板“门票”",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/18013427854354.shtml",
    "datetime": "2019-07-18 01:34:24",
    "code": "688321"
  },
  {
    "title": "1个月后微芯生物科创板终获注册成功 实控人：现在心情很平常",
    "href": "http://stock.jrj.com.cn/2019/07/17231427854122.shtml",
    "datetime": "2019-07-17 23:14:27",
    "code": "688321"
  },
  {
    "title": "一波三折！从“难产”到“顺产” 微芯生物上演惊魂42天",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/17221727854030.shtml",
    "datetime": "2019-07-17 22:17:29",
    "code": "688321"
  },
  {
    "title": "微芯生物科创板“注册生效”",
    "href": "http://stock.jrj.com.cn/2019/07/17213827853956.shtml",
    "datetime": "2019-07-17 21:38:00",
    "code": "688321"
  },
  {
    "title": "每经小强快讯：注册生效！深圳微芯生物科技股份有限公司科创板挂牌只等“这一天”了",
    "href": "http://stock.jrj.com.cn/2019/07/17213127853933.shtml",
    "datetime": "2019-07-17 21:31:17",
    "code": "688321"
  },
  {
    "title": "大反转！微芯生物苦等27天终于拿到证监会批文",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/17212727853906.shtml",
    "datetime": "2019-07-17 21:27:42",
    "code": "688321"
  },
  {
    "title": "证监会同意微芯生物科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2019/07/17195527853647.shtml",
    "datetime": "2019-07-17 19:55:00",
    "code": "688321"
  },
  {
    "title": "证监会同意微芯生物科创板首次公开发行股票注册",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/17195127853638.shtml",
    "datetime": "2019-07-17 19:51:43",
    "code": "688321"
  },
  {
    "title": "微芯生物无缘首发 生物药企叫好不叫座",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/16033027844456.shtml",
    "datetime": "2019-07-16 03:30:31",
    "code": "688321"
  },
  {
    "title": "微芯生物闯关科创板疑虑：美国区收入跳水 销售费用增幅远超研发",
    "href": "http://stock.jrj.com.cn/2019/07/12074927830290.shtml",
    "datetime": "2019-07-12 07:49:00",
    "code": "688321"
  },
  {
    "title": "证监会:微芯生物等6家申请注册企业注册状态为\"进一步问询中\"",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/05211527803409.shtml",
    "datetime": "2019-07-05 21:15:06",
    "code": "688321"
  },
  {
    "title": "证监会：微芯生物等6家申请注册企业的注册状态为进一步问询中",
    "href": "http://stock.jrj.com.cn/2019/07/05211527803414.shtml",
    "datetime": "2019-07-05 21:15:00",
    "code": "688321"
  },
  {
    "title": "微芯生物总裁鲁先平：生物医药产业核心技术创新仍不足",
    "href": "http://stock.jrj.com.cn/2019/06/28133527769302.shtml",
    "datetime": "2019-06-28 13:35:26",
    "code": "688321"
  },
  {
    "title": "微芯生物董事长谈科创板申报经验：注重信披真实性",
    "href": "http://stock.jrj.com.cn/2019/06/27005527760770.shtml",
    "datetime": "2019-06-27 00:55:48",
    "code": "688321"
  },
  {
    "title": "微芯生物董事长谈科创板申报经验：踏实，注重信披真实性",
    "href": "http://stock.jrj.com.cn/2019/06/26220427760448.shtml",
    "datetime": "2019-06-26 22:04:24",
    "code": "688321"
  },
  {
    "title": "微芯生物将成科创板生物医药第一股",
    "href": "http://stock.jrj.com.cn/2019/06/20031027727459.shtml",
    "datetime": "2019-06-20 03:10:55",
    "code": "688321"
  },
  {
    "title": "掀开科创板公司红盖头|微芯生物靠“西达本胺”一战成名",
    "href": "http://stock.jrj.com.cn/2019/06/13150527699918.shtml",
    "datetime": "2019-06-13 15:05:00",
    "code": "688321"
  },
  {
    "title": "微芯生物等3家公司提交科创板注册申请",
    "href": "http://stock.jrj.com.cn/2019/06/11181827687623.shtml",
    "datetime": "2019-06-11 18:18:00",
    "code": "688321"
  },
  {
    "title": "[国投资本]安信证券助力微芯生物首家科创板成功过会",
    "href": "http://stock.jrj.com.cn/2019/06/06000027671923.shtml",
    "datetime": "2019-06-06 00:00:00",
    "code": "688321"
  },
  {
    "title": "科创板首批3家公司全过会 正式挂牌或在7月初",
    "href": "http://stock.jrj.com.cn/2019/06/05170027667815.shtml",
    "datetime": "2019-06-05 17:00:38",
    "code": "688321"
  },
  {
    "title": "微芯生物：实控人认定受关注",
    "href": "http://stock.jrj.com.cn/2019/06/05165127667772.shtml",
    "datetime": "2019-06-05 16:51:38",
    "code": "688321"
  },
  {
    "title": "华立股份澄清：未持有微芯生物股份",
    "href": "http://stock.jrj.com.cn/2019/05/28182827633691.shtml",
    "datetime": "2019-05-28 18:28:59",
    "code": "688321"
  },
  {
    "title": "微芯生物，80亿估值到底贵不贵",
    "href": "http://stock.jrj.com.cn/2019/05/22104227606341.shtml",
    "datetime": "2019-05-22 10:42:00",
    "code": "688321"
  },
  {
    "title": "微芯生物率先回复第三轮问询 实控人认定和风险因素受关注",
    "href": "http://stock.jrj.com.cn/2019/05/21030527598008.shtml",
    "datetime": "2019-05-21 03:05:34",
    "code": "688321"
  },
  {
    "title": "微芯生物成首家科创板“三试”考生",
    "href": "http://stock.jrj.com.cn/2019/05/21011927597916.shtml",
    "datetime": "2019-05-21 01:19:44",
    "code": "688321"
  },
  {
    "title": "微芯生物“闪答”科创板第三轮问询",
    "href": "http://stock.jrj.com.cn/2019/05/21002727597815.shtml",
    "datetime": "2019-05-21 00:27:21",
    "code": "688321"
  },
  {
    "title": "首家公司回复科创板第三轮问询 这几大问题受关注",
    "href": "http://stock.jrj.com.cn/2019/05/20212627596871.shtml",
    "datetime": "2019-05-20 21:26:30",
    "code": "688321"
  },
  {
    "title": "第三轮！科创板上市受理企业微芯生物回复三轮问询",
    "href": "http://stock.jrj.com.cn/2019/05/20190327596573.shtml",
    "datetime": "2019-05-20 19:03:20",
    "code": "688321"
  },
  {
    "title": "微芯生物成首个回答上交所二问公司：重点关注研发支出的资本化和费用化",
    "href": "http://stock.jrj.com.cn/2019/05/15111727572449.shtml",
    "datetime": "2019-05-15 11:17:01",
    "code": "688321"
  },
  {
    "title": "重点更突出 科创板二轮问询回复出炉",
    "href": "http://stock.jrj.com.cn/2019/05/15035527570803.shtml",
    "datetime": "2019-05-15 03:55:52",
    "code": "688321"
  },
  {
    "title": "微芯生物回复二轮问询 聚焦关键问题提示主要风险",
    "href": "http://stock.jrj.com.cn/2019/05/15034727570784.shtml",
    "datetime": "2019-05-15 03:47:39",
    "code": "688321"
  },
  {
    "title": "科创板申报企业提交首份第二轮“问答” 微芯生物逾10万字回应",
    "href": "http://stock.jrj.com.cn/2019/05/15004627570584.shtml",
    "datetime": "2019-05-15 00:46:14",
    "code": "688321"
  },
  {
    "title": "首家！科创板上市受理企业微芯生物回复二轮问询",
    "href": "http://stock.jrj.com.cn/2019/05/14184927569819.shtml",
    "datetime": "2019-05-14 18:49:56",
    "code": "688321"
  },
  {
    "title": "微芯生物：研发投入占比超五成 产品单一或是潜在风险",
    "href": "http://stock.jrj.com.cn/2019/05/08070727540694.shtml",
    "datetime": "2019-05-08 07:07:52",
    "code": "688321"
  },
  {
    "title": "实探传音控股与微芯生物：办公地点简单 经营实力不凡",
    "href": "http://stock.jrj.com.cn/2019/04/26080227489094.shtml",
    "datetime": "2019-04-26 08:02:00",
    "code": "688321"
  },
  {
    "title": "科创板首批问询函回复出炉 微芯生物回应股权结构、专利授权等41问",
    "href": "http://stock.jrj.com.cn/2019/04/24002627469870.shtml",
    "datetime": "2019-04-24 00:26:52",
    "code": "688321"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，深圳微芯生物科技股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/04/23193927468328.shtml",
    "datetime": "2019-04-23 19:39:19",
    "code": "688321"
  },
  {
    "title": "科创板上市受理企业深圳微芯生物已回复上交所问询",
    "href": "http://stock.jrj.com.cn/2019/04/23175327467644.shtml",
    "datetime": "2019-04-23 17:53:39",
    "code": "688321"
  },
  {
    "title": "科创板受理企业微芯生物已回复上交所问询",
    "href": "http://stock.jrj.com.cn/2019/04/23175327467652.shtml",
    "datetime": "2019-04-23 17:53:00",
    "code": "688321"
  },
  {
    "title": "每经小强快讯：深圳微芯生物科技股份有限公司及安信证券股份有限公司关于审核问询函的回复",
    "href": "http://stock.jrj.com.cn/2019/04/23174627467614.shtml",
    "datetime": "2019-04-23 17:46:03",
    "code": "688321"
  },
  {
    "title": "搜于特：公司投资的创投企业间接参股微芯生物",
    "href": "http://stock.jrj.com.cn/2019/04/10111727359981.shtml",
    "datetime": "2019-04-10 11:17:24",
    "code": "688321"
  }
]